MRC Epidemiology  >  People | Printer Friendly

Rebecca Simmons

Contact Details

Picture of Rebecca Simmons

Rebecca Simmons
MRC Epidemiology Unit
Institute of Metabolic Science
Box 285
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 0QQ

Tel: +44 (0)1223 769159
Fax: +44 (01223) 330316
email: rebecca.simmons@mrc-epid.cam.ac.uk

 

Rebecca Simmons is an Investigator Scientist working on the prevention of chronic disease. She read Human Sciences at Hertford College, Oxford, and Epidemiology at the London School of Hygiene & Tropical Medicine. She subsequently carried out research into the primary prevention of diabetes and obtained her PhD from the MRC Epidemiology Unit, at Wolfson College, Cambridge.  Rebecca’s current research focuses on risk identification, screening and the primary and secondary prevention of diabetes and cardiovascular disease. She is particularly interested in developing primary prevention strategies for larger groups of people at lower absolute risk of chronic disease. Rebecca is involved in teaching epidemiology and statistics to Cambridge medical and veterinary students and MPhil Epidemiology students. She is also a tutor on the London School's distance learning MSc course in Epidemiology.


Selected publications

  1. Griffin SJ, Borch-Johnsen K, Davies M, Khunti K, Lauritzen T, Rutten GEHM, Sandbæk A, Sharp S, Simmons RK, van den Donk M, Wareham NJ. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011; 378: 156-167.
  2. Buijsse B, Simmons RK, Griffin SJ, Schulze M. Risk prediction tools for identifying individuals at risk for type 2 diabetes. Epidemiologic Reviews 2011; 33(1):46-62.
  3. Chamnan P, Simmons RK, Forouhi N, Luben R, Khaw K-T, Wareham NJ, Griffin SJ. Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the EPIC-Norfolk cohort: implications for preventive strategies. Diabetes Care 2011; 34(4):950-6.
  4. Simmons RK, Rahman M, Jakes R, Yuyun M, Niggebrugge AR, Hennings SH, Williams DRR, Wareham NJ, Griffin SJ. Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. Diabetologia 2011; 54(2): 312-319
  5. Chamnan P, Simmons RK, Jackson R, Khaw K-T, Wareham NJ, Griffin SJ. Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 2011; 54(2):291-299.
  6. Simmons RK, Echouffo-Tcheugui JB, Griffin SJ. Screening for type 2 diabetes: an update of the evidence. Diabetes Obesity & Metabolism 2010; 12:838-844.
  7. Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. British Medical Journal 2010; 340:c1693.
  8. Simmons RK, Unwin N, Griffin SJ. International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes. Diabetes Research Clinical Practice 2010; 87: 143-149.
  9. Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven R, Hama Sambo B, Mendis S, Roglic G. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53(4):597-9.

Unit Publications :: With Abstracts